It’s important for clinicians to assess patients undergoing percutaneous coronary intervention (PCI) for both anemia and chronic kidney disease (CKD).

Portolés J, Martín L, Broseta JJ, Cases A. Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents. Front Med (Lausanne). 2021;8:642296. doi:10.3389/fmed ...

Stockholm, Sweden - 1 August 2025 - Modus Therapeutics Holding AB (publ) ("Modus") today announces that dose levels for Part 2 of its ongoing Phase IIa clinical study of sevuparin in patients with chr ...

The optimal target hemoglobin level for anemic patients with chronic kidney disease (CKD) is controversial. Two new randomized trials, both supported by makers of erythropoietin and both conducted ...

The Bottom Line "Medical professionals should be aware of the anemia associated with inflammation, including iron deficiency and anemia of chronic disease, in the management of these diseases ...

The connection between anemia and heart disease in women is one of the most underdiagnosed and undertreated health relationships in modern medicine. Doctors often treat these as separate ...

Anemia is a common and clinically significant comorbidity in chronic obstructive pulmonary disease (COPD), contributing to worsened respiratory function, reduced exercise capacity and overall ...